Erectile dysfunction;Erektile dysfunktion

Aktuelle Neurologie

Volumn 27, Issue 1, 2000, Pages 1-12

  Hilz, M J ^a   Hecht, M ^a   Kolsch C ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; APOMORPHINE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; CYCLIC AMP; CYCLIC GMP; GUANYLATE CYCLASE; NEUROPEPTIDE Y; NITRIC OXIDE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE; PROLACTIN; PROSTAGLANDIN E1; SILDENAFIL; TESTOSTERONE; TRAZODONE; VASOACTIVE INTESTINAL POLYPEPTIDE; YOHIMBINE;

ADRENERGIC SYSTEM; ANGIOGRAPHY; CAVERNOSOGRAPHY; CHOLINERGIC SYSTEM; CORPUS CAVERNOSUM; DOPPLER ECHOGRAPHY; ELECTROMYOGRAM; ELECTROSTIMULATION THERAPY; ERECTILE DYSFUNCTION; HUMAN; PENIS ARTERY; PSYCHOTHERAPY; REVASCULARIZATION; REVIEW; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY;

EID: 0034048826     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. NIH consensus development panel on impotence. Impotence. Jama 1993; 270: 83-90
2. Feldmann HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61
3. Singer C, Weiner WJ. Male sexual dysfunction. The Neurologist 1996; 2: 119-129
4. Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med 1989; 321: 1648-1659
5. Lue PF. Impotence after prostatectomy. Urol Clin North Am 1990; 40: 1347-1349
6. Schmidt P, Jünemann KP. Physiologische Grundlagen der Erektion. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 188-197
7. Comarr AE. Sexual function among patients with spinal cord injury. Urol Int 1992; 25: 134-168
8. Jünemann KP, Persson-Jünemann C, Lue TF et al. Neurophysiological aspects of penile erection. Urol Res 1989; 17: 213-217
9. Brindley GS. Neurophysiology. In: Kirby RS, Carson CC, Webster GD (eds): Impotence: Diagnosis and management of male erectile dysfunction. Oxford: Butterworth-Heinemann Ltd, 1991: 27-31
10. Prackett NL, Bloch WE, Abae M. Neurological anatomy and physiology of sexual function. In: Singer C, Weiner WJ (eds): Sexual Dysfunction: A neuromedical approach. Armonk, NY: Futura publishing, 1994: 1-4
11. Wein AJ, van Arsdalen KN. Drug-induced male sexual dysfuncion. Urol Clin North Am 1988; 15: 23-31
12. Boller F, Frank E. Sexual dysfunction in neurological disorders. New York: Raven Press, 1982
13. Kirkeby HJ, Jorgenson JC, Ottensen B. Neuropeptid Y (NPY) in human penile corpus cavernosum tissue and circum flex veins: Occurence and in vitro effects. J Urol 1991; 145: 605-609
14. Pickard RS. The role of nitric oxide and other neurotransmitters in erectile function. Curr Opin Urol 1996; 6: 347-351
15. Weiss HD. The physiology of human penile erection. Ann Intern Med 1972; 76: 793-799
16. Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrin Metab Clin N Am 1996; 25: 379-400
17. Andersson K-E, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236
18. Aoki H, Matsuzaka J, Yeh KH et al. Involvement of vasoactive intestinal polypeptide (VIP) as a humoral mediator of penile erection function in the dog. J Androl 1994; 15: 174-182
19. Ding YQ, Takada M, Kaneko T et al. Colocalization of vasoactive intestinal peptide and nitric oxide in penis-innervating neurones in the major pelvic ganglia of the rat. Neurosci Res 1995; 22: 129-131
20. Ückert S. Intrazelluläre Mechanismen der Tonusregulation. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 197-205
21. Porst H, Ebeling L. Erektile Dysfunktion. Übersicht und aktueller Stand von Diagnostik und Therapie. Fortschr Med 1989; 107: 88-93
22. Wagner G, Green R. Impotence. New York: Plenum, 1981
23. Popken G, Wetterauer U. Pathophysiologie von Erektionsstörungen. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 205-217
24. Angermann I. Psychodynamik und Psychotherapie der gestörten Sexualität. In: Eicher W (Hrsg): Sexualmedizin in der Praxis. Stuttgart: Fischer, 1980
25. Becker N. Psychoanalytische Ansätze bei der Therapie sexueller Funktionstörungen. In Sigusch V (Hrsg): Sexuelle Störungen und ihre Behandlung. Stuttgart: Thieme, 1997: 166-179
26. Kokott G. Sexuelle Funktionsstörungen des Mannes. Stuttgart: Enke, Beitr. Sexualforsch. 58, 1981
27. Hartmann U. Grundlagen der Entstehung psychogener Erektionsstörungen. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 220-230
28. Kulzer B. Verhaltentherapie bei Diabetes Mellitus. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 300-312
29. Ellenberg M. Impotence in diabetes: the neurologic factor. Ann Intern Med Vol. 75: 213
30. Jevtich MJ, Kass M, Khavand M. Changes in the corpora cavernosa of impotent diabetics. Comparing histological with clinical findings. J Urol (Paris) 1985; 91: 281
31. McVary KT, Rathnau CH, McKenna KE. Sexual dysfunction in the diabetic BB/WOR rat: a role of central neuropathy. Am J Physiol 1997; 272: R259-R267
32. Aoki H, Fujioka T, Matsuzaka J et al. Suppression by prolactin of the electrically induced erectile response through ist direct effect on the corpus cavernosum penis in the dog. J Urol 1995; 154: 595-600
33. Chamness SL, Ricker DD, Cfrone JK et al.: The effect of androgen on nitric oxide-mediated relaxation of the rabbit corpus cavernosum. Br J Pharmacol 1995; 115: 15-18
34. LuggJA, Rajfer J, Gonzalez-Cadavid N. Dihydrotestosterone is the active androgen in thze maintenance of nitric oxide-mediated penile erection in the rat. Fertil Steril 1995; 63: 1101-1107
35. Abramowicz M. Drugs that cause sexual dysfunction: An update. Med Lett Drugs Ther 1992; 34: 73-78
36. Malone PR, Cook A, Edmonson R et al. Prostatectomy. Br J Urol 1988; 61: 234
37. Walsh PC, Donker P. Impotence following radical retropubic prostatectomy. J Urol 1982; 128: 492
38. Whitelaw GT, Smithwick RH. Some secondary effets of sympathectomy. N EnglJ Med 1951; 245: 121-128
39. Robinson BW, Mishkin M. Penile erection evoked from forebrain structures in Macaca mulatta. Arch Neurol 1968; 19: 184-198
40. Lilius HG, Valtonen EJ, Wikstrom J. Sexual problems in patients suffering from multiple sclerosis. Scand J Soc Med 1976; 4: 41-44
41. Valleroy ML, Kraft GH Sexual dysfunction in multiple sclerosis. Arch Phys Med Rehabil 1984; 65: 125-128
42. Wenning GK, Ben Shlomo Y, Magalhaes M et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994; 117: 835-845
43. Sanders DB. Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies. Ann Neurol 1995; 37: 63-73
44. Kirby RS, Eardley I. Initial assessment of patients with erectile dysfunction. In: Kirby RS, Carson CC, Webster GD (eds): Impotence: diagnosis and management of male erectile dysfunction. Oxford: Butterworth-Heinemann Ltd, 1991: 57-61
45. Stief CG, Hartmann U. Diagnostik. Praktisches Vorgehen und kritische Wertung. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 96-105
46. Hagemann JH, Stief CG. Doppler-Duplex- und farbkodierte Duplexuntersuchung der penilen Gefäße. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 141-159
47. Donatucci CF, Lue TF. The combined intracavernous injection and stimulation test: diagnostic accuracy. J Urol 1992; 148: 61-62
48. Stief CG, Jünemann KP, Porst H et al. Die intrakavernöse Anwendung verschiedener Substanzen zur Schwellkörperautoinjektionstherapie - Standortbestimmung. Urologe [B] 1993; 33: 2-5
49. Porst H. Rationale for Prostaglandin E1 in erectile failure: A survey of world wide and world experience. Review Article. J Urol 1996; 155: 802-815
50. Roy AC, Adaikan PG, Sen DK et al. Prostaglandin 15-hydroxydehydrogenase activity in human penile corpora cavernosa and ist significance in prostaglandin-mediated penile erection. Br J Urol 1989; 64: 180-182
51. Kaufman JM, Borges FD, Fitch WP III et al. Evaluation of erectile dysfunction by dynamic infusion cavernosometry and cavernossography (DICC). Urology 1993; 41: 445-451
52. Wespes E, Delcour C, Struyven J et al. Cavernometry-cavernography: ist role in organic impotence. Eur Urol 1984; 10: 229-232
53. Schervan A. Penisangiographie bei erektiler Dysfunktion. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 177-185
54. Machtens SA, Becker AJ. Pharmakocavernosometrie und-graphie in der Diagnostik des venösen Verschlussmechanismus des Corpus cavernosum. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 169-176
55. Fowler CJ. Electrophysiologic evaluation of sexual dysfunction. In: Low, P. A. (ed): Clinical autonomic disorders. Boston, Toronto, London: Little, Brown and Company, 1992: 279-285
56. Pedersen E. Electromyography of the sphincter muscles. Contemp Clin Neurophysiol 1978; 34: 405-416
57. Sakuta M, Nakanishi T, Toyokura Y. Anal muscle electromyograms differ in amyotrophic lateral sclerosis and Shy-Drager-syndrome. Neurology 1978; 28: 1289-1293
58. Vodusek DB, Janko M, Lokar J. Direct and reflex responses in perineal muscles on electrical stimulation. J Neurol Neurosurg Psychiatry 1983; 46: 67-71
59. Kiff ES, Swash M. Normal proximal and delayed distal conduction in the pudendal nerves of patients with idiopathic (neurogenic) faecal incontinence. J Neurol Neurosurg Psychiatry 1984; 47: 820-823
60. Ghezzi A, Callea L, Zaffaroni M et al. Motor potentials of bulbocavernosus muscle after transcranial and lumbar magnetic stimulation: comparative study with bulbocavernosus reflex and pudendal evoked potentials. J Neurol Neurosurg Psychiatry 1991; 54: 524-526
61. Jost WH, Schimrigk K. A new method to determine pudendal nerve motor latency and central motor conduction time to the external anal sphincter. Electroenc Clin Neurophysiol 1994; 93: 237-239
62. Derouet H, Jost WH. Neurophysiologische Untersuchungen. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 160-169
63. Gerstenberg TC, Nordling J, Halt P et al. Standardized evaluation of erectile dysfunction in 95 consecutive patients. J Urol 1989; 141: 857-862.
64. Stief CG, Djamilian M, Schaebsdauf-Truss MC et al. Single potential analysis of cavernosous activity - a possible diagnosis of autonomic impotence? World J Urol 1990; 8: 75-79
65. Stief CG, Thon WF, Djamilian M et al. Transcutaneous registration of cavernous smooth muscle electric activity. Non-invasive diagnosis of neurogenic autonomie impotence. World J Urol 1990; 8: 75-79
66. Wagner G, Gerstenberg TC, Levin RJ. Electrical activity of corpus cavernosum during flaccidity and erection of the human penis: a new diagnostic method? J Urol 1989; 42: 723-725
67. Derouet H. Erektile Funktionsstörungen, Diagnostik, Therapie und Begutachtung. Berlin, Heidelberg, New York: Springer, 1992
68. Stief CG, Hartmann U. Therapieoptionen. Praktisches Vorgehen und kritische Wertung. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 14-44
69. Steffens J, Derouet H, Moll V et al. Erektionsring - Nichtoperative therapeutische Alternative bei venogener Impotenz. Urologe [B] 1989; 29: 158-161
70. Wetterauer U, Stief CG, Kulvelis F et al. The electron microscopic ultrastructure of cavernous tissue in erectile dysfunction (abstract). J Urol 1990; 143: 509 A
71. Trimble MH, Enoka RM. Mechanisms underlying the training effects associated with neuromuscular electrical stimulation. Phys Ther 1991; 71: 273-281
72. Stief CG, Weller E, Noack T et al. Functional electromyostimulation of the corpus cavernosum penis (FEMCC): a new therapeutic option for erectile dysfunction. Urologe [A] 1995; 35: 321-325
73. Cookson MS, Phillips DL, Huff ME et al. Analysis of microsurgical penile revascularization results by etiology of impotence. J Urol 1993; 149: 1308-1312
74. Hauri D. Therapiemöglichkeiten bei der vaskulär bedingten erektilen Impotenz. Akt Urol 1984; 15: 350-354
75. Schultheiss D, Truss MC, Becker AJ et al. Long-term results following dorsal penile vein ligation in 126 patients with venoocclusive dysfunction. Int J Impot Res 1997; 9: 205-209
76. Freedman AL, Costa Neto F, Mehringer CM et al. Long-term results of penile vein ligation for impotence from venous leakage. J Urol 1993; 149: 1301-1303
77. Wespes E, Schulman C. Venous impotence: pathophysiology, diagnosis and treatment. J Urol 1993; 149: 1238-1245
78. Bogoras NA. Über die volle plastische Wiederherstellung eines zum Koitus fähigen Penis (Peniplastica totalis). Zentralbl Chir 1936; 63: 1271
79. Schultheiß D, Jonas U. Penisimplantate ("Penisprothesen"). In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 83-91
80. Virag R, Sussmann H, Floresco J et al. Late results on the treatment of neurogenic impotence by self-intracavernous Injektion (SICI) of vasoactive drugs. World J Urol 1987; 5: 166
81. Ismail M, Abbott L, Hirsch IH. Experience with intracavernous PGE-1 in the treatment of erectile dysfunction: dose considerations and effiacy. Int J Impot Res 1997; 9: 39-42
82. Linet OI, Ogrinc FG. Effiacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 1996; 334: 873-877
83. Porst H, Buvat J, Hauri D et al. Self-injection therapy with prostaglandin E1. Long-term results of an international multicenter study according to the GCP-standard. Int J Impotence Res 1994; 6: D108
84. Stackl W, Hasun R, Marberger M. Intracavernous injection of prostaglandin E1 in impotent men. J Urol 1988; 140: 66-68
85. Padma-Nathan H, Hellstrom W, Kaiser FE et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 1997; 336: 1
86. Höfner K, Stief CG. Intraurethrale Applikation vasoaktiver Substanzen. In: Stief CG, Hartmann U, Höfner K et al. (Hrsg): Erektile Dysfunktion, Diagnostik und Therapie. Berlin, Heidelberg, New York: Springer, 1997: 64f
87. Susset JG, Tessier CD, Wincze J et al. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol 1989; 141:1360-1363
88. Heaton JP, Adams MA, Morales A et al. Apomorphine SL is effective in the treatment of non-organic erectile dysfunction. Int J Impotence Res 1996; 8: 115
89. Kurt U, Ozkardes H, Altug U et al. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction. J Urol 1994; 152: 407-409
90. Morales A, Johnston B, Heaton JW et al. Oral androgens in the treatment of hypogonadal impotent men. J Urol 1994; 152: 1115-1118
91. Arzneimittelkommission der Deutschen Ärzteschaft. Hinweise zur sicheren Anwendung von Dildenafil (Viagra®). Deutsches Ärzteblatt 1998; 95: B2103-2104
92. Garban H, Marquez D et al. Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol Reprod 1997; 56: 954-963
93. Schroeder-Printzen I, Schroeder-Printzen J, Weidner W et al. Diagnostik und Therapie der erektilen Dysfunktion - eine Leistung der gesetzlichen Krankenversicherung? Urologe [A] 1994; 33: 252-256
94. Jänig W. Genitalreflexe beim Manne. In: Schmidt RF, Thews G (Hrsg): Physiologie des Menschen. Berlin, Heidelberg, New York: Springer, 1983: 137-139